Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A cream to fight obesity is being ignored

George Lundberg, MD
Meds
August 7, 2011
Share
Tweet
Share

Do you, or many of your patients, have a little more belly fat around your and their middle than you and they would like? Me, too.

Turns out that there are two decent published studies from reputable places that report that a person may rub a cream on their skin over the fat spots and make the fat go away.

Wow, what a deal.

The first study addresses fat thighs, with each person in the study using one thigh as the test and the other as the control.

This 1995 study from UCLA included renowned obesity researcher Professor George Bray as an author, is published in the journal called Obesity Research.

The second study is from LSU in Baton Rouge and addresses waist circumference.

All participants were placed on a diet of restricted calories and required to exercise. The test group rubbed a cream on the waist and the control group did not.

After 12 weeks, both groups had lost waist circumference but the cream group lost a lot more.

This paper was published in 2007 in the journal called Diabetes, Obesity and Metabolism.

The eminent evidence-based medicine review group at McMaster University in Canada included the second study in their Best Evidence series. I selected it to highlight in another journal in 2008 and that concurrent text-audio-video article is in PubMedCentral.

The main substance in the magic cream is the common drug aminophylline at 0.5% concentration.

The chemical effect is plausible but the test numbers in these studies are small. In 2008, I asked that additional clinical trials be undertaken. But, I have not found any more such results published, positive or negative. Maybe no drug company considered this worth its while to fund studies.

Caveats:

  • Even if this treatment works, it is no panacea; obesity is a complex disease.
  • The subcutaneous fat that may be lost by this treatment is not the main culprit for diabetes, etc; visceral fat is, unaffected by the cream.
  • You might be able to purchase this aminophylline cream on the Internet. If you go to a pharmacy to buy it, you will be asked for a prescription and the pharmacy might have to compound the 0.5% aminophylline mix for you.

My interest is curiosity and clinical. Of course, I have no financial interest.

I hope that well-planned clinical trials are in process somewhere.

ADVERTISEMENT

All in all, if you want to lose fatty girth, I think this is worth a try. Risks and costs seem trivial. Gains could be substantial.

George Lundberg is a MedPage Today Editor-at-Large and former editor of the Journal of the American Medical Association.

Originally published in MedPage Today. Visit MedPageToday.com for more primary care news.

Prev

Dangers of the hospital press release

August 7, 2011 Kevin 2
…
Next

There is no billing code for compassion

August 7, 2011 Kevin 12
…

Tagged as: Medications

Post navigation

< Previous Post
Dangers of the hospital press release
Next Post >
There is no billing code for compassion

ADVERTISEMENT

More by George Lundberg, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Pathologists face a stark career choice

    George Lundberg, MD
  • a desk with keyboard and ipad with the kevinmd logo

    A culture of cover-up has slowed the patient safety movement

    George Lundberg, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Do drugs aid and abet genius or does genius lead to drugs?

    George Lundberg, MD

More in Meds

  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
    • The debate on English tests for immigrant nurses

      Lynne Moronski, PhD, MPA, RN | Conditions
    • The FQHC model and medicine’s moral promise

      Sami Sinada, MD | Physician
    • AI companions and loneliness

      Ronke Lawal | Tech
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • Who profits from medical malpractice lawsuits?

      Howard Smith, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
    • The decline of the doctor-patient relationship

      William Lynes, MD | Physician
    • Diagnosing the epidemic of U.S. violence

      Brian Lynch, MD | Physician
    • A neurosurgeon’s fight with the state medical board [PODCAST]

      The Podcast by KevinMD | Podcast
    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
    • The stoic cure for modern anxiety

      Osmund Agbo, MD | Physician
  • Recent Posts

    • Celebrating internal medicine through our human connections with patients

      American College of Physicians | Education
    • The debate on English tests for immigrant nurses

      Lynne Moronski, PhD, MPA, RN | Conditions
    • The FQHC model and medicine’s moral promise

      Sami Sinada, MD | Physician
    • AI companions and loneliness

      Ronke Lawal | Tech
    • The frustrating bureaucracy of getting a vaccine

      Richard A. Lawhern, PhD | Conditions
    • Who profits from medical malpractice lawsuits?

      Howard Smith, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

A cream to fight obesity is being ignored
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...